Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein
- PMID: 12062037
- DOI: 10.1016/s0896-6273(02)00682-7
Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein
Abstract
alpha-Synucleinopathies are neurodegenerative disorders that range pathologically from the demise of select groups of nuclei to pervasive degeneration throughout the neuraxis. Although mounting evidence suggests that alpha-synuclein lesions lead to neurodegeneration, this remains controversial. To explore this issue, we generated transgenic mice expressing wild-type and A53T human alpha-synuclein in CNS neurons. Mice expressing mutant, but not wild-type, alpha-synuclein developed a severe and complex motor impairment leading to paralysis and death. These animals developed age-dependent intracytoplasmic neuronal alpha-synuclein inclusions paralleling disease onset, and the alpha-synuclein inclusions recapitulated features of human counterparts. Moreover, immunoelectron microscopy revealed that the alpha-synuclein inclusions contained 10-16 nm wide fibrils similar to human pathological inclusions. These mice demonstrate that A53T alpha-synuclein leads to the formation of toxic filamentous alpha-synuclein neuronal inclusions that cause neurodegeneration.
Similar articles
-
Exacerbated synucleinopathy in mice expressing A53T SNCA on a Snca null background.Neurobiol Aging. 2005 Jan;26(1):25-35. doi: 10.1016/j.neurobiolaging.2004.02.026. Neurobiol Aging. 2005. PMID: 15585343
-
Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.Science. 2000 Feb 18;287(5456):1265-9. doi: 10.1126/science.287.5456.1265. Science. 2000. PMID: 10678833
-
Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration.Neuron. 2005 Mar 24;45(6):847-59. doi: 10.1016/j.neuron.2005.01.032. Neuron. 2005. PMID: 15797547
-
Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1101-18. doi: 10.1098/rstb.1999.0466. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434313 Free PMC article. Review.
-
Neuropathological spectrum of synucleinopathies.Mov Disord. 2003 Sep;18 Suppl 6:S2-12. doi: 10.1002/mds.10557. Mov Disord. 2003. PMID: 14502650 Review.
Cited by
-
Binding of the radioligand SIL23 to α-synuclein fibrils in Parkinson disease brain tissue establishes feasibility and screening approaches for developing a Parkinson disease imaging agent.PLoS One. 2013;8(2):e55031. doi: 10.1371/journal.pone.0055031. Epub 2013 Feb 6. PLoS One. 2013. PMID: 23405108 Free PMC article.
-
Lipid and Transcriptional Regulation in a Parkinson's Disease Mouse Model by Intranasal Vesicular and Hexosomal Plasmalogen-Based Nanomedicines.Adv Healthc Mater. 2024 Jun;13(14):e2304588. doi: 10.1002/adhm.202304588. Epub 2024 Feb 28. Adv Healthc Mater. 2024. PMID: 38386974 Free PMC article.
-
Restoration of intestinal function in an MPTP model of Parkinson's Disease.Sci Rep. 2016 Jul 29;6:30269. doi: 10.1038/srep30269. Sci Rep. 2016. PMID: 27471168 Free PMC article.
-
Bee venom phospholipase A2 ameliorates motor dysfunction and modulates microglia activation in Parkinson's disease alpha-synuclein transgenic mice.Exp Mol Med. 2016 Jul 8;48(7):e244. doi: 10.1038/emm.2016.49. Exp Mol Med. 2016. PMID: 27388550 Free PMC article.
-
Dysregulation of MicroRNAs and PIWI-Interacting RNAs in a Caenorhabditis elegans Parkinson's Disease Model Overexpressing Human α-Synuclein and Influence of tdp-1.Front Neurosci. 2021 Mar 8;15:600462. doi: 10.3389/fnins.2021.600462. eCollection 2021. Front Neurosci. 2021. PMID: 33762903 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous